Show simple item record

dc.contributor.authorEuropean Phelan-McDermid syndrome consortium
dc.contributor.authorLandlust, Annemiek M
dc.contributor.authorKoza, Sylvia A
dc.contributor.authorCarbin, Maya
dc.contributor.authorWalinga, Margreet
dc.contributor.authorRobert, Sandra
dc.contributor.authorCooke, Jennifer
dc.contributor.authorVyshka, Klea
dc.contributor.authorvan Balkom, Ingrid D C
dc.contributor.authorvan Ravenswaaij-Arts, Conny
dc.date.accessioned2025-01-17T17:45:01Z
dc.date.available2025-01-17T17:45:01Z
dc.date.issued2023-07-30
dc.identifier.citationEuropean Phelan-McDermid syndrome consortium , Landlust , A M , Koza , S A , Carbin , M , Walinga , M , Robert , S , Cooke , J , Vyshka , K , van Balkom , I D C & van Ravenswaaij-Arts , C 2023 , ' Parental perspectives on Phelan-McDermid syndrome: Results of a worldwide survey ' , European journal of medical genetics , vol. 66 , no. 7 , 104771 . https://doi.org/10.1016/j.ejmg.2023.104771
dc.identifier.issn1769-7212
dc.identifier.urihttp://hdl.handle.net/2299/28710
dc.description© 2023 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
dc.description.abstractPhelan-McDermid syndrome (PMS) is a rare neurodevelopmental disorder characterised by hypotonia, speech problems, intellectual disability and mental health issues like regression, autism and mood disorders. In the development, implementation and dissemination of a new clinical guideline for a rare genetic disorder like PMS, the parental experienced perspective is essential. As information from literature is scarce and often conflicting the European Phelan-McDermid syndrome guideline consortium created a multi-lingual survey for parents of individuals with PMS to collect their lived experiences with care needs, genotypes, somatic issues, mental health issues and parental stress. In total, we analysed 587 completed surveys from 35 countries worldwide. Based on parental reporting, PMS appeared to be caused by a deletion of chromosome 22q13.3 in 78% (379/486) of individuals and by a variant in the SHANK3 gene in 22% (107/486) of the individuals. Parents reported a wide variety of developmental, neurological, and other clinical issues in individuals with PMS. The most frequently experienced issues were related to speech and communication, learning disabilities/intellectual disability, and behaviour. While most reported issues were present across all age groups and genotypes, the prevalence of epilepsy, lymphoedema, and mental health issues do appear to vary with age. Developmental regression also appeared to begin earlier in this cohort than described in literature. Individuals with PMS due to a 22q13.3 deletion had a higher rate of kidney issues and lymphoedema compared to individuals with SHANK3 variants. Parental stress was high, with specific contributing factors being child and context related in accordance with the PMS phenotype. The survey results led to various validated recommendations in the European PMS guideline including an age specific surveillance scheme, specific genetic counselling, structured healthcare evaluations on sleep and communication and a focus on family well-being.en
dc.format.extent9
dc.format.extent1143924
dc.language.isoeng
dc.relation.ispartofEuropean journal of medical genetics
dc.subjectHumans
dc.subjectIntellectual Disability/genetics
dc.subjectChromosome Disorders/genetics
dc.subjectChromosome Deletion
dc.subjectParents
dc.subjectChromosomes, Human, Pair 22/genetics
dc.titleParental perspectives on Phelan-McDermid syndrome: Results of a worldwide surveyen
dc.contributor.institutionDepartment of Psychology, Sport and Geography
dc.contributor.institutionSchool of Life and Medical Sciences
dc.description.statusPeer reviewed
rioxxterms.versionofrecord10.1016/j.ejmg.2023.104771
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record